澳门澳彩资料大全正版资料下载,香港六合管家婆资料,澳门免费资料最准的,澳门正版资料大全公开

MENU

FIND DOCTORS

Name: Ping Bo
Department: PATHOLOGY
Title:Associate Professor

 
 
 
Education & Professional Experience   2007-now Associate Professor, Department of Pathology, Fudan University Cancer Hospital, Shanghai, P. R. China

2003-2005 Visiting Scientist, Molecular and Cellular Oncology, M.D. Anderson Cancer Center, University of Texas, Houston, Texas, U.S.

2000-2007 Attending Doctor, Department of Pathology, Fudan University Cancer Hospital, Shanghai, P. R. China

2000-2006 PhD, Department of Oncology, Fudan University, Shanghai, P. R. China

1997-1998 Visiting Scholar, Lab of Cytology, Anatomical Pathology, Concord Repatriation General Hospital, Sydney, Australia

1995-2000Resident, Department of Pathology, Shanghai Medical University Cancer Hospital (now Fudan University Cancer Hospital), Shanghai, P. R. China

1990-1995 Bachelor of Medicine, Shanghai Medical University (now Fudan University), Shanghai, P. R. China
 
 
Specialty   Cytopathology, Molecular Pathology
 
 
Research   Cervical cancer, Hematopoietic and lymphoid tumor
 
 
Publication   Zhang T, Tu X, Xu W, Ping B, Huang Z, Wang J, Chen T, Chen Z. A study of prognostic factors in breast cancer:histological grading. Chinese Journal of Pathology. 1998;(6):5-7

Ma D, Wang L, Ping B. Clinical Significance of fine needle aspiration of thyroid nodules. Journal of Surgery Concepts & Practice. 1999;(4): 6-8

Ping B, Zhu X, Shen M. Review: Significance of squamous differentiated cells in thyroid fine needle aspirations. Chinese Journal of Diagnostic Pathology. 2001; 8(1): 49-51

Ping B, Wang L, Lu H, Fen L, Xu W, Zhu X, Shi D. Application of fine needle aspiration biopsies in the diagnosis of primary and metastatic medullary thyroid carcinoma. Chinese Journal of Clinical and Experimental Pathology, 2001; 17(5): 392-395

Ping B, Sun M, Lu H, Xu Y, Zhang T, Shi D. Microsatellite analysis of coding mononucleotide repeats in nodal non-Hodgkin's lymphomas. Chinese Journal of Clinical and Experimental Pathology. 2003; 19(4):16-19

Ping B, Sun M, Zhang T, Cai Q, Lu H, Xu Y, Shi D. Microsatellite analysis of BAT-26 and BAT-25 in nodal non-Hodgkin'slymphomas. China Oncology. 2004; 14(1): 24-27

Shen M, Ping B. Thyroid cytology and its clinical significance. In: Yang Y. Diagnosis and differential diagnosis of endocrine diseases. Tianjin science and technology press, Tianjin, 2004: 90-100

Wang J, Ping B. Pathological diagnosis. In: Jiang G. Modern clinical oncology. Shanghai science and technology literature press, Shanghai, 2004: 10-16

Ping B, Wang L. Cytological diagnosis of gastric cancers. In: Liu Q, Wang W, Mao H. Gastric cancers. People’s medical publishing house, Beijing, 2004: 309-317

Shao R, Lee DF, Wen Y, Ding Y, Xia W, Ping B, Yagita H, Spohn B, Hung MC. E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation. Mol Cancer Res. 2005; 3(4):219-226

Cha TL, Zhou BP, Xia W, Wu Y, Yang CC, Chen CT, Ping B, Otte AP, Hung MC. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science. 2005; 310(5746):306-310

Ping B, He X, Xia W, Lee DF, Wei Y, Yu D, Mills G, Shi D, Hung MC. Cytoplasmic expression of p21CIP1/WAF1 is correlated with IKKbeta overexpression in human breast cancers. Int J Oncol. 2006; 29(5):1103-1110

Lee DF, Kuo HP, Chen CT, Hsu JM, Sun HL, Chou CK, Wei Y, Li LY, Ping B, Huang WC, He X, Hung JY, Lai CC, Ding Q, Su JL, Yang JY, Sahin AA, Hortobagyi GN, Tsai FJ, Tsai CH, Hung MC. Suppression of TSC1 by IKKb confers tumor angiogenesis through the mTOR pathway. Cell. 2007; 130(3):440-455

Wang P, Meng ZQ, Chen Z, Lin JH, Ping B, Wang LF, Wang BH, Liu LM. Diagnostic value and complications of fine needle aspiration for primary liver cancer and its influence on the treatment outcome-a study based on 3011 patients in China. Eur J Surg Oncol. 2008; 34(5);541-546

Liu ZB, Wu J, Ping B, Feng LQ, Di GH, Lu JS, Shen KW, Shen ZZ, Shao ZM. Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype. Tumori. 2009;95(1):53-62
 
 
Awards   N/A
 
 
Out-patient Schedule  

N/A